2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Circulating Tumor Cell: new trials by email Literature Review of Circulating Tumor Cell trials Research Report on Circulating Tumor Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Liquid Biopsy (ctDNA) Guided Treatment in Localized Pancreatic Cancer: Neoadjuvant CTX vs. Upfront Surgery Neoadjuvant chemotherapy instead of upfront surgery, Upfront surgery - Pancreatic Cancer, Circulating Tumor Cell | Phase 2 | Active not recruiting | Elisabethinen Hospital | 100 | 2024-01-11 | 2026-11-03 |
| Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II-III FOLFOXIRI, CAPOX - Colorectal Neoplasms Malignant, Minimal Residual Disease | Phase 2 | Active not recruiting | Fundación para la Investigación del Hospital Clínico de Valencia | 45 | 2022-01-01 | 2026-09-15 |
Neoplastic Cells, Circulating (2) · Colonic Neoplasms (1) · Neoplasm, Residual (1) · Pancreatic Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Neoplasms by Site (2) · Neoplastic Processes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Colonic Diseases (1) · Colorectal Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1)
FOLFOXIRI protocol (1) · Standard of Care (1)
Elisabethinen Hospital (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1)
Austria (1) · Spain (1)